Dr. Singh received a Bachelor's degree in biology in 2006, graduating magna cum laude with academic distinction from Cornell University. He subsequently enrolled in the Medical Scientist Training Program at the University of Pennsylvania, where he received his medical degree as well as a PhD in Cell and Molecular Biology under the mentorship of Dr. Jonathan Epstein. His doctoral research concerned the epigenetic regulation of neural crest development, and he was able to relate his basic science findings to aspects of human coronary artery disease, as well as to the development of lipid-induced heart failure. He was then accepted into the ABIM Research Pathway at Yale New Haven Hospital, where he completed his internal medicine residency training and a clinical fellowship in nephrology.
Dr. Singh is board certified in internal medicine and eligible for certification in nephrology in 2018. He is currently a postdoctoral fellow at the Yale School of Medicine, under the mentorship of Dr. Lloyd Cantley in the Section of Nephrology. In his work in the Cantley lab, Dr. Singh uses principles of developmental biology to better understand the barriers to regeneration in the acutely injured human kidney. He is currently studying progenitor cell populations involved in the development and regeneration of the mammalian kidney, and is using novel techniques to analyze human kidney samples obtained through collaborations with the departments of Urology and Transplant Surgery at Yale New Haven Hospital.
Education & Training
|MD||University of Pennsylvania, Raymond and Ruth Perelman School of Medicine (2013)|
|PhD||University of Pennsylvania, Department of Developmental, Stem Cell and Regenerative Biology (2012)|
|BA||Cornell University (2006)|